Best treatments for glycogen storage disease type ii
3 products may treat glycogen storage disease type ii. The current highest-rated option is myozyme. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for glycogen storage disease type ii, none are yet flagged as generics in our price data. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for glycogen storage disease type ii — so confirm the right choice with your prescriber.
Top-rated picks for glycogen storage disease type ii: 1. Myozyme · 2. Nexviazyme · 3. Pombiliti
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Injectable | — | No data | — | View → | |
| 2 | 70/100 | Prescription | Injectable | — | No data | — | View → | |
| 3 | Not yet rated | Prescription | Injectable | — | No data | — | View → |
Full ranking · 3 treatments
myozyme
PrescriptionFDA-sourced
Myozyme (Alglucosidase Alfa) is a medication used to treat Glycogen Storage Disease Type II.
Price varies
nexviazyme
Boxed warningPrescriptionFDA-sourced
Nexviazyme (Avalglucosidase Alfa-Ngpt) is a medication used to treat Glycogen Storage Disease Type II.
Price varies
pombiliti
Boxed warningPrescriptionFDA-sourced
Pombiliti (Cipaglucosidase Alfa-Atga) is a medication used to treat Glycogen Storage Disease Type II.
Price varies
Frequently asked
- What treats glycogen storage disease type ii?
- Our catalog lists 3 products that may treat glycogen storage disease type ii, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is myozyme.
- What is the best-rated treatment for glycogen storage disease type ii?
- By our independent recall-safety rating — not an efficacy measure — myozyme ranks highest among the products we list for glycogen storage disease type ii. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.